Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial

BACKGROUND: Pre-exposure prophylaxis (PrEP) is a promising strategy to break COVID-19 transmission. Although hydroxychloroquine was evaluated for treatment and post-exposure prophylaxis, it is not evaluated for COVID-19 PrEP yet. The aim of this study was to evaluate the efficacy and safety of PrEP...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau-Pujol, Berta, Camprubí-Ferrer, Daniel, Marti-Soler, Helena, Fernández-Pardos, Marc, Carreras-Abad, Clara, Andrés, Maria Velasco-de, Ferrer, Elisabet, Muelas-Fernandez, Magdalena, Jullien, Sophie, Barilaro, Giuseppe, Ajanovic, Sara, Vera, Isabel, Moreno, Laura, Gonzalez-Redondo, Eva, Cortes-Serra, Núria, Roldán, Montserrat, Arcos, Ana Artes-de, Mur, Isabel, Domingo, Pere, Garcia, Felipe, Guinovart, Caterina, Muñoz, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591593/
https://www.ncbi.nlm.nih.gov/pubmed/34781981
http://dx.doi.org/10.1186/s13063-021-05758-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591593/
https://www.ncbi.nlm.nih.gov/pubmed/34781981
http://dx.doi.org/10.1186/s13063-021-05758-9

Ejemplares similares